Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rhinitis | 27 | 2024 | 747 | 6.530 |
Why?
|
Sinusitis | 28 | 2024 | 991 | 5.700 |
Why?
|
Nasal Polyps | 15 | 2024 | 395 | 3.930 |
Why?
|
Paranasal Sinus Neoplasms | 10 | 2024 | 242 | 2.420 |
Why?
|
Aerosols | 9 | 2021 | 635 | 2.100 |
Why?
|
Cilia | 10 | 2024 | 492 | 2.040 |
Why?
|
Paranasal Sinuses | 11 | 2024 | 265 | 1.870 |
Why?
|
Taste | 8 | 2023 | 189 | 1.420 |
Why?
|
Respiratory Mucosa | 7 | 2018 | 438 | 1.390 |
Why?
|
Endoscopy | 14 | 2024 | 1851 | 1.370 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 4 | 2023 | 250 | 1.350 |
Why?
|
Nasal Mucosa | 6 | 2019 | 415 | 1.250 |
Why?
|
Otolaryngology | 6 | 2024 | 693 | 1.240 |
Why?
|
Nose | 5 | 2023 | 521 | 1.180 |
Why?
|
Receptors, G-Protein-Coupled | 9 | 2020 | 1250 | 1.040 |
Why?
|
Chronic Disease | 26 | 2024 | 9311 | 0.890 |
Why?
|
Anti-Anxiety Agents | 2 | 2023 | 397 | 0.880 |
Why?
|
Nose Neoplasms | 3 | 2018 | 249 | 0.750 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3088 | 0.710 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3209 | 0.710 |
Why?
|
Olfactory Mucosa | 1 | 2021 | 101 | 0.700 |
Why?
|
Cautery | 1 | 2020 | 71 | 0.690 |
Why?
|
Nose Diseases | 1 | 2020 | 79 | 0.670 |
Why?
|
Proteome | 2 | 2020 | 1857 | 0.660 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2020 | 119 | 0.650 |
Why?
|
Suction | 1 | 2020 | 266 | 0.650 |
Why?
|
Eosinophilia | 1 | 2024 | 559 | 0.640 |
Why?
|
Quinine | 1 | 2018 | 51 | 0.610 |
Why?
|
Focal Infection, Dental | 1 | 2018 | 26 | 0.610 |
Why?
|
Maxillary Sinusitis | 1 | 2018 | 41 | 0.590 |
Why?
|
Respiratory System | 2 | 2018 | 563 | 0.580 |
Why?
|
Nasopharynx | 1 | 2020 | 400 | 0.570 |
Why?
|
Nitric Oxide | 6 | 2019 | 2135 | 0.570 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2020 | 324 | 0.550 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2020 | 339 | 0.550 |
Why?
|
Ophthalmic Solutions | 1 | 2017 | 312 | 0.510 |
Why?
|
Military Personnel | 1 | 2024 | 1245 | 0.480 |
Why?
|
Particulate Matter | 2 | 2024 | 2602 | 0.480 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2024 | 9277 | 0.470 |
Why?
|
Candida albicans | 1 | 2017 | 372 | 0.460 |
Why?
|
Cadaver | 5 | 2020 | 1358 | 0.450 |
Why?
|
Consensus | 1 | 2023 | 3117 | 0.450 |
Why?
|
Leiomyosarcoma | 1 | 2017 | 422 | 0.450 |
Why?
|
Calcium Channels | 1 | 2017 | 620 | 0.440 |
Why?
|
Thyroid Nodule | 1 | 2020 | 764 | 0.430 |
Why?
|
Salivary Cystatins | 2 | 2022 | 11 | 0.370 |
Why?
|
Adenosine Triphosphate | 1 | 2017 | 1988 | 0.370 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2023 | 3708 | 0.360 |
Why?
|
Disease Transmission, Infectious | 3 | 2020 | 561 | 0.360 |
Why?
|
Biological Evolution | 2 | 2013 | 1070 | 0.350 |
Why?
|
Glucocorticoids | 1 | 2020 | 2160 | 0.350 |
Why?
|
Veterans | 1 | 2024 | 2649 | 0.350 |
Why?
|
Head and Neck Neoplasms | 3 | 2020 | 2894 | 0.340 |
Why?
|
Papilloma, Inverted | 2 | 2019 | 19 | 0.340 |
Why?
|
Bacteria | 2 | 2018 | 2192 | 0.340 |
Why?
|
Humans | 82 | 2024 | 760617 | 0.330 |
Why?
|
Epithelial Cells | 4 | 2019 | 3672 | 0.330 |
Why?
|
Pandemics | 6 | 2021 | 8645 | 0.330 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1779 | 0.320 |
Why?
|
Respiratory Tract Diseases | 1 | 2014 | 750 | 0.320 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2008 | 0.310 |
Why?
|
Chemoreceptor Cells | 2 | 2019 | 89 | 0.310 |
Why?
|
Mucociliary Clearance | 3 | 2024 | 80 | 0.300 |
Why?
|
Particle Size | 2 | 2024 | 1648 | 0.300 |
Why?
|
Esthesioneuroblastoma, Olfactory | 2 | 2018 | 58 | 0.300 |
Why?
|
Thyroid Neoplasms | 1 | 2020 | 2332 | 0.280 |
Why?
|
Anti-Infective Agents | 1 | 2014 | 983 | 0.280 |
Why?
|
Self Report | 1 | 2018 | 3723 | 0.280 |
Why?
|
Quaternary Ammonium Compounds | 2 | 2017 | 202 | 0.270 |
Why?
|
Neurogenesis | 1 | 2013 | 862 | 0.270 |
Why?
|
Immunity, Innate | 6 | 2022 | 3045 | 0.250 |
Why?
|
Asymptomatic Diseases | 2 | 2019 | 587 | 0.240 |
Why?
|
Exosomes | 2 | 2020 | 424 | 0.240 |
Why?
|
Models, Neurological | 1 | 2013 | 1768 | 0.240 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4020 | 0.240 |
Why?
|
Kuwait | 1 | 2024 | 92 | 0.230 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2024 | 97 | 0.220 |
Why?
|
Biological Products | 2 | 2024 | 912 | 0.220 |
Why?
|
Ageusia | 1 | 2023 | 18 | 0.220 |
Why?
|
Mastoid | 2 | 2020 | 100 | 0.220 |
Why?
|
Afghan Campaign 2001- | 1 | 2024 | 298 | 0.210 |
Why?
|
Macrolides | 1 | 2024 | 204 | 0.210 |
Why?
|
Hemangioma, Cavernous | 1 | 2023 | 107 | 0.200 |
Why?
|
Smell | 2 | 2023 | 259 | 0.200 |
Why?
|
Postoperative Care | 2 | 2020 | 1467 | 0.200 |
Why?
|
Verapamil | 1 | 2022 | 242 | 0.190 |
Why?
|
Adult | 22 | 2024 | 220969 | 0.190 |
Why?
|
Male | 32 | 2024 | 360358 | 0.190 |
Why?
|
Middle Aged | 22 | 2024 | 220584 | 0.180 |
Why?
|
Hypersensitivity | 2 | 2021 | 1167 | 0.180 |
Why?
|
Orbital Neoplasms | 1 | 2023 | 222 | 0.180 |
Why?
|
Sneezing | 1 | 2020 | 17 | 0.180 |
Why?
|
Olfaction Disorders | 1 | 2023 | 224 | 0.180 |
Why?
|
Medicare Part D | 2 | 2024 | 354 | 0.180 |
Why?
|
Private Practice | 1 | 2021 | 153 | 0.170 |
Why?
|
Female | 31 | 2024 | 392148 | 0.170 |
Why?
|
Middle Ear Ventilation | 1 | 2020 | 101 | 0.170 |
Why?
|
Mycetoma | 1 | 2019 | 18 | 0.160 |
Why?
|
Neoplasm Invasiveness | 2 | 2017 | 3593 | 0.160 |
Why?
|
Combined Modality Therapy | 4 | 2019 | 8516 | 0.160 |
Why?
|
Antigens, Fungal | 1 | 2019 | 69 | 0.160 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2019 | 89 | 0.160 |
Why?
|
Otologic Surgical Procedures | 1 | 2020 | 150 | 0.160 |
Why?
|
Cell Extracts | 1 | 2019 | 135 | 0.160 |
Why?
|
Ear Diseases | 1 | 2020 | 180 | 0.150 |
Why?
|
Taste Buds | 1 | 2018 | 24 | 0.150 |
Why?
|
Population Groups | 1 | 2019 | 207 | 0.150 |
Why?
|
Rhinoplasty | 1 | 2022 | 238 | 0.150 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7402 | 0.150 |
Why?
|
Otitis Media | 1 | 2020 | 286 | 0.150 |
Why?
|
Interleukin-17 | 3 | 2019 | 911 | 0.150 |
Why?
|
Erectile Dysfunction | 1 | 2021 | 444 | 0.150 |
Why?
|
Radiography, Dental | 1 | 2018 | 54 | 0.150 |
Why?
|
Receptor, PAR-2 | 1 | 2017 | 33 | 0.150 |
Why?
|
Bacillus cereus | 1 | 2017 | 36 | 0.150 |
Why?
|
Survival Analysis | 3 | 2019 | 10073 | 0.140 |
Why?
|
Mucus | 1 | 2019 | 342 | 0.140 |
Why?
|
Office Visits | 1 | 2021 | 593 | 0.140 |
Why?
|
Sucrose | 1 | 2017 | 158 | 0.140 |
Why?
|
Aflatoxins | 1 | 2016 | 12 | 0.140 |
Why?
|
Air | 1 | 2017 | 187 | 0.140 |
Why?
|
Cytodiagnosis | 1 | 2020 | 447 | 0.140 |
Why?
|
Respiratory Hypersensitivity | 1 | 2018 | 274 | 0.140 |
Why?
|
Virus Diseases | 1 | 2022 | 718 | 0.140 |
Why?
|
Pennsylvania | 1 | 2017 | 612 | 0.130 |
Why?
|
Aspergillus | 1 | 2016 | 93 | 0.130 |
Why?
|
Neck Dissection | 1 | 2017 | 201 | 0.130 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 262 | 0.130 |
Why?
|
Tracheostomy | 1 | 2020 | 426 | 0.130 |
Why?
|
Pseudomonas | 1 | 2016 | 124 | 0.130 |
Why?
|
Hospitals, University | 1 | 2017 | 564 | 0.130 |
Why?
|
Free Tissue Flaps | 1 | 2020 | 331 | 0.130 |
Why?
|
Surgery, Oral | 1 | 2018 | 130 | 0.130 |
Why?
|
Drug Delivery Systems | 2 | 2019 | 2222 | 0.130 |
Why?
|
Anatomy | 1 | 2017 | 126 | 0.130 |
Why?
|
Connexins | 1 | 2017 | 352 | 0.130 |
Why?
|
Biopsy, Fine-Needle | 1 | 2020 | 1118 | 0.130 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1879 | 0.130 |
Why?
|
Cognition | 1 | 2013 | 6987 | 0.120 |
Why?
|
Off-Label Use | 1 | 2017 | 185 | 0.120 |
Why?
|
Aged | 17 | 2024 | 169042 | 0.120 |
Why?
|
Allergens | 2 | 2022 | 1429 | 0.120 |
Why?
|
Prednisone | 1 | 2020 | 1562 | 0.120 |
Why?
|
Host-Pathogen Interactions | 2 | 2021 | 1454 | 0.120 |
Why?
|
Chlorides | 1 | 2017 | 665 | 0.120 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2017 | 342 | 0.120 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2018 | 1033 | 0.120 |
Why?
|
Neoplasm Staging | 3 | 2019 | 11116 | 0.120 |
Why?
|
Prescription Drugs | 1 | 2021 | 631 | 0.110 |
Why?
|
Immunomodulation | 1 | 2018 | 548 | 0.110 |
Why?
|
Skull Base Neoplasms | 1 | 2017 | 270 | 0.110 |
Why?
|
Up-Regulation | 2 | 2020 | 4117 | 0.110 |
Why?
|
Carcinoma in Situ | 1 | 2019 | 791 | 0.110 |
Why?
|
Trichosurus | 1 | 2013 | 1 | 0.110 |
Why?
|
Macropodidae | 1 | 2013 | 11 | 0.110 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2018 | 474 | 0.110 |
Why?
|
Gerbillinae | 1 | 2013 | 87 | 0.110 |
Why?
|
Adjuvants, Immunologic | 1 | 2019 | 990 | 0.110 |
Why?
|
Outpatients | 1 | 2021 | 1596 | 0.110 |
Why?
|
Pituitary Neoplasms | 1 | 2022 | 1323 | 0.110 |
Why?
|
Retrospective Studies | 13 | 2024 | 80566 | 0.110 |
Why?
|
Occupational Exposure | 2 | 2020 | 1813 | 0.110 |
Why?
|
Radiology, Interventional | 1 | 2017 | 476 | 0.110 |
Why?
|
Th2 Cells | 1 | 2018 | 1056 | 0.110 |
Why?
|
Pseudomonas Infections | 1 | 2017 | 621 | 0.100 |
Why?
|
Prospective Studies | 5 | 2023 | 54360 | 0.100 |
Why?
|
Ferrets | 1 | 2013 | 177 | 0.100 |
Why?
|
Health Expenditures | 2 | 2024 | 2361 | 0.100 |
Why?
|
Asthma | 2 | 2024 | 6233 | 0.100 |
Why?
|
Databases, Factual | 5 | 2019 | 7960 | 0.100 |
Why?
|
Bronchi | 1 | 2016 | 846 | 0.100 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2017 | 1784 | 0.100 |
Why?
|
Rare Diseases | 1 | 2017 | 622 | 0.100 |
Why?
|
Proteomics | 3 | 2022 | 3836 | 0.100 |
Why?
|
Risk Assessment | 3 | 2018 | 23972 | 0.100 |
Why?
|
Macaca | 1 | 2013 | 410 | 0.100 |
Why?
|
Cats | 1 | 2013 | 975 | 0.100 |
Why?
|
Biofilms | 1 | 2016 | 626 | 0.100 |
Why?
|
Antiviral Agents | 2 | 2022 | 3039 | 0.100 |
Why?
|
Guinea Pigs | 1 | 2013 | 1310 | 0.090 |
Why?
|
Comorbidity | 2 | 2023 | 10505 | 0.090 |
Why?
|
Microbial Sensitivity Tests | 1 | 2017 | 1936 | 0.090 |
Why?
|
Prognosis | 4 | 2019 | 29600 | 0.090 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6807 | 0.090 |
Why?
|
Sheep | 1 | 2013 | 1436 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1810 | 0.090 |
Why?
|
Cricetinae | 1 | 2013 | 2424 | 0.080 |
Why?
|
Animals | 9 | 2022 | 168201 | 0.080 |
Why?
|
Recurrence | 2 | 2019 | 8426 | 0.080 |
Why?
|
Brain | 2 | 2013 | 27101 | 0.080 |
Why?
|
Pseudomonas aeruginosa | 1 | 2017 | 1272 | 0.080 |
Why?
|
Treatment Outcome | 10 | 2023 | 64568 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2630 | 0.080 |
Why?
|
Species Specificity | 1 | 2013 | 2411 | 0.080 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 697 | 0.080 |
Why?
|
Health Care Costs | 1 | 2021 | 3238 | 0.080 |
Why?
|
Education, Medical, Undergraduate | 1 | 2017 | 1068 | 0.080 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3451 | 0.080 |
Why?
|
Medicare | 3 | 2024 | 6765 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2650 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4739 | 0.070 |
Why?
|
Critical Care | 1 | 2020 | 2690 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6474 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2021 | 22148 | 0.070 |
Why?
|
Rabbits | 1 | 2013 | 4770 | 0.070 |
Why?
|
Cohort Studies | 3 | 2019 | 41457 | 0.070 |
Why?
|
Disease Progression | 3 | 2019 | 13495 | 0.070 |
Why?
|
Cystic Fibrosis | 1 | 2015 | 1285 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26049 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12447 | 0.070 |
Why?
|
Staphylococcal Infections | 1 | 2015 | 1406 | 0.070 |
Why?
|
United States | 7 | 2024 | 72272 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3634 | 0.070 |
Why?
|
Phenotype | 3 | 2019 | 16571 | 0.060 |
Why?
|
Health Status Disparities | 1 | 2017 | 1846 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15828 | 0.060 |
Why?
|
Cells, Cultured | 5 | 2019 | 18937 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 4408 | 0.060 |
Why?
|
Nasal Lavage | 1 | 2023 | 17 | 0.060 |
Why?
|
Curriculum | 1 | 2017 | 3738 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2019 | 12758 | 0.060 |
Why?
|
Logistic Models | 1 | 2018 | 13245 | 0.060 |
Why?
|
Dysgeusia | 1 | 2023 | 15 | 0.060 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58894 | 0.050 |
Why?
|
Taste Disorders | 1 | 2023 | 38 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14648 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5332 | 0.050 |
Why?
|
Calcium Signaling | 2 | 2017 | 734 | 0.050 |
Why?
|
Biological Therapy | 1 | 2024 | 139 | 0.050 |
Why?
|
Inflammation | 2 | 2022 | 10760 | 0.050 |
Why?
|
Poly I-C | 1 | 2022 | 112 | 0.050 |
Why?
|
Budesonide | 1 | 2023 | 157 | 0.050 |
Why?
|
Toll-Like Receptor 3 | 1 | 2022 | 97 | 0.050 |
Why?
|
Quality of Life | 3 | 2021 | 13347 | 0.050 |
Why?
|
Mice, Knockout | 1 | 2017 | 14389 | 0.050 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2022 | 188 | 0.050 |
Why?
|
Endoscopes | 1 | 2022 | 168 | 0.050 |
Why?
|
Taste Perception | 1 | 2020 | 37 | 0.040 |
Why?
|
Insulin-Like Growth Factor Binding Protein 4 | 1 | 2020 | 24 | 0.040 |
Why?
|
Insulin-Like Growth Factor Binding Protein 5 | 1 | 2020 | 28 | 0.040 |
Why?
|
Fluorescein | 1 | 2020 | 175 | 0.040 |
Why?
|
Time Factors | 2 | 2019 | 39913 | 0.040 |
Why?
|
Young Adult | 4 | 2020 | 59179 | 0.040 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 1 | 2020 | 60 | 0.040 |
Why?
|
Otitis Media with Effusion | 1 | 2020 | 115 | 0.040 |
Why?
|
Discriminant Analysis | 1 | 2019 | 223 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2022 | 624 | 0.040 |
Why?
|
Alternaria | 1 | 2019 | 42 | 0.040 |
Why?
|
Biomedical Research | 1 | 2014 | 3426 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22115 | 0.040 |
Why?
|
Eye Diseases | 1 | 2024 | 653 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2020 | 15612 | 0.040 |
Why?
|
Cough | 1 | 2023 | 595 | 0.040 |
Why?
|
Hypophysectomy | 1 | 2018 | 114 | 0.040 |
Why?
|
Risk Factors | 3 | 2020 | 74115 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39063 | 0.040 |
Why?
|
Transducin | 1 | 2018 | 42 | 0.040 |
Why?
|
Dilatation | 1 | 2020 | 306 | 0.040 |
Why?
|
Exhalation | 1 | 2019 | 181 | 0.040 |
Why?
|
Molecular Typing | 1 | 2018 | 116 | 0.040 |
Why?
|
Genotype | 3 | 2018 | 12978 | 0.040 |
Why?
|
Hospitals, Community | 1 | 2020 | 365 | 0.040 |
Why?
|
Aspergillus fumigatus | 1 | 2019 | 157 | 0.040 |
Why?
|
Phospholipase C beta | 1 | 2017 | 49 | 0.040 |
Why?
|
Bodily Secretions | 1 | 2017 | 28 | 0.040 |
Why?
|
Administration, Intranasal | 1 | 2019 | 476 | 0.040 |
Why?
|
Bacteriolysis | 1 | 2017 | 50 | 0.040 |
Why?
|
Mice | 4 | 2022 | 81368 | 0.040 |
Why?
|
Skull Base | 1 | 2020 | 292 | 0.040 |
Why?
|
Appointments and Schedules | 1 | 2021 | 442 | 0.030 |
Why?
|
Phenylthiourea | 1 | 2016 | 10 | 0.030 |
Why?
|
Rats | 1 | 2013 | 23717 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2017 | 384 | 0.030 |
Why?
|
Administration, Oral | 1 | 2024 | 4010 | 0.030 |
Why?
|
TRPM Cation Channels | 1 | 2017 | 139 | 0.030 |
Why?
|
Facial Paralysis | 1 | 2020 | 346 | 0.030 |
Why?
|
Drugs, Generic | 1 | 2021 | 448 | 0.030 |
Why?
|
Fungi | 1 | 2019 | 338 | 0.030 |
Why?
|
Temporal Bone | 1 | 2020 | 683 | 0.030 |
Why?
|
Gastrointestinal Diseases | 1 | 2024 | 1201 | 0.030 |
Why?
|
Interleukin-13 | 1 | 2018 | 392 | 0.030 |
Why?
|
Cell Membrane Permeability | 1 | 2017 | 574 | 0.030 |
Why?
|
Cytokines | 2 | 2022 | 7373 | 0.030 |
Why?
|
Microscopy | 1 | 2020 | 905 | 0.030 |
Why?
|
Metagenome | 1 | 2018 | 448 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2023 | 1661 | 0.030 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2017 | 352 | 0.030 |
Why?
|
Patient Readmission | 2 | 2020 | 3269 | 0.030 |
Why?
|
Endocrinology | 1 | 2020 | 442 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36402 | 0.030 |
Why?
|
Operating Rooms | 1 | 2020 | 789 | 0.030 |
Why?
|
Occupational Health | 1 | 2020 | 806 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2018 | 1471 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2018 | 1697 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 982 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1813 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2019 | 2700 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2020 | 1932 | 0.020 |
Why?
|
Incidence | 2 | 2020 | 21337 | 0.020 |
Why?
|
Phylogeny | 1 | 2018 | 2806 | 0.020 |
Why?
|
Arthroscopy | 1 | 2017 | 969 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 2913 | 0.020 |
Why?
|
Educational Measurement | 1 | 2017 | 1252 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4300 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2022 | 2896 | 0.020 |
Why?
|
Income | 1 | 2017 | 1870 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9604 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2872 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8833 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2018 | 5863 | 0.020 |
Why?
|
Base Sequence | 1 | 2018 | 12421 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2018 | 4242 | 0.020 |
Why?
|
Anxiety | 1 | 2022 | 4570 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6418 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12719 | 0.020 |
Why?
|
Insurance, Health | 1 | 2017 | 2495 | 0.020 |
Why?
|
Mass Screening | 1 | 2020 | 5424 | 0.010 |
Why?
|
Prevalence | 1 | 2021 | 15689 | 0.010 |
Why?
|
Medicaid | 1 | 2017 | 2814 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12043 | 0.010 |
Why?
|
Cell Line | 1 | 2017 | 15576 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15251 | 0.010 |
Why?
|
Genetic Variation | 1 | 2018 | 6561 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8132 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29868 | 0.010 |
Why?
|
Adolescent | 2 | 2016 | 88234 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23416 | 0.010 |
Why?
|